Monday, June 8, 2009
Elizabeth Laur, email@example.com
+1 414-276-2145 (MDS Secretariat)
MDS 13th International Congress Press Room (June 7-11):
Le Palais des Congres de Paris,
Room 212/213, Level 2, Hall Maillot, TEL: +33 (0)1 40 68 63 74
Creativity Induced by Dopamine Agonists in Parkinson's Disease
PARIS - A study investigating the link to creativity in Parkinson's disease to dopamine agonist therapy was presented today at The Movement Disorder Society's 13th International Congress of Parkinson's Disease and Movement Disorders.
This study looked at PD patients who underwent deep brain stimulation. The researchers found that creativity disappears after STN surgery, when dopamine replacement therapy is too drastically reduced. The study was led by a team of scientists led by Alina Batir, MD, and colleagues from Grenoble, France who researched creativity in patients with Parkinson's disease.
Researchers showed that creativity in PD is linked to dopamine agonist therapy. When patients undergo deep brain stimulation, their creativity seems to disappear when the dopamine replacement therapy is reduced too much.
Meeting attendees are gathered to learn the latest research findings and state-of-the-art treatment options for Movement Disorders, including Parkinson's disease. More than 3,900 physicians and medical professionals from 90 countries will be able to view over 1,700 scientific abstracts submitted by clinicians from around the world.
The Movement Disorder Society, an international society of over 3,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research.
For more information about The Movement Disorder Society, visit www.movementdisorders.org